IceCure Medical Ltd
ICCM
$0.30
$0.00-0.33%
NASDAQ
| 12/31/2024 | 12/31/2024 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Net Income | -7.95% | -7.95% | -34.66% | ||
| Total Depreciation and Amortization | -1.20% | -1.20% | 1.22% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 11.39% | 11.39% | 4.66% | ||
| Change in Net Operating Assets | -103.23% | -103.23% | 60.50% | ||
| Cash from Operations | -33.05% | -33.05% | -33.43% | ||
| Capital Expenditure | 84.38% | 84.38% | -433.33% | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -100.24% | -100.24% | 200.00% | ||
| Cash from Investing | -100.87% | -100.87% | 195.49% | ||
| Total Debt Issued | -- | -- | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -52.72% | -52.72% | 77.72% | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -67.22% | -67.22% | 77.72% | ||
| Foreign Exchange rate Adjustments | -175.00% | -175.00% | 300.00% | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | -404.91% | -404.91% | 177.55% | ||